Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    Oncology nurse education
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    January 13, 2023
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    Pancreatic cancer
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    November 11, 2022
    The Life of Marie Curie and Her Contributions to Oncology
    Cancer treatments
    The Life of Marie Curie and Her Contributions to Oncology
    November 07, 2022
    Post-Flooding Natural Disaster Cancer Considerations and Patient Education Points
    Patient safety
    Post-Flooding Natural Disaster Cancer Considerations and Patient Education Points
    September 28, 2022
    Can Patients Use Continuous Glucose Monitors During Radiation Therapy for Cancer?
    Radiation therapy
    Can Patients Use Continuous Glucose Monitors During Radiation Therapy for Cancer?
    August 19, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Research

    NINR Promotes Nursing Research to Achieve Health Equity
    Research

    NINR Promotes Nursing Research to Achieve Health Equity

    To address and achieve equity in health care, in fall 2022 the National Institute of Nursing Research (NINR) began offering new funding opportunities for research studies aligned with the scientific framework outlined in the institute’s 2022–2026 strategic plan. The grants are available cyclically with three application periods per year.

    January 24, 2023
    Use Active Listening to Engage More Deeply in Patient Discussions
    Research

    Use Active Listening to Engage More Deeply in Patient Discussions

    In your day-to-day conversations with patients, colleagues, or even friends and family at home, are you merely hearing what others tell you or are you actively listening to them? When we actively listen to what someone is saying, we intreat curiosity about their words and the emotions they are communicating with their tone and body language. Active listening engages a whole-person connection, whereas passive listening relies on the brain’s ability to catch the main points of a conversation.

    January 24, 2023
    NIH-Funded Studies Show Damaging Effects of Vaping, Smoking on Blood Vessels
    Patient safety

    NIH-Funded Studies Show Damaging Effects of Vaping, Smoking on Blood Vessels

    Long-term use of vaping products can significantly impair the body’s blood vessel functioning, increasing a person’s risk for cardiovascular disease, researchers for two studies supported by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, reported in October 2022. The researchers also found that combined use of e- and regular cigarettes may increase that risk even further than use of either product alone.

    January 10, 2023
    New Cancer Drugs Launch at Record-High Prices
    Prescription medication

    New Cancer Drugs Launch at Record-High Prices

    Inflating more than 50% since 2017, the annual price of newly launched cancer drugs averages $283,000 in 2022, according to a new report from the office of U.S. Representative Katie Porter (D-CA). Although new drugs for any condition are also seeing record-breaking high prices, the cost of new anticancer therapeutics is 3.7 times higher than that of non-oncology drugs.

    December 14, 2022
    Even During Routine Cancer Care, Financial Hardship Significantly Increases Mortality
    Patient financial advocacy

    Even During Routine Cancer Care, Financial Hardship Significantly Increases Mortality

    Patients with cancer experiencing financial hardship during routine care are nearly 1.5 times more likely to die than those who aren’t, researchers reported in study findings published in JCO Oncology Practice.

    December 13, 2022
    OSTP Makes Federally Funded Research Easily Accessible to the Public
    Research

    OSTP Makes Federally Funded Research Easily Accessible to the Public

    The White House Office of Science and Technology Policy updated policy guidance in August 2022 to allow the average American easier access to publications. The new guidance applies to taxpayer-funded research studies and makes the results publicly available for free.

    December 13, 2022
    Arati Prabhakar Becomes First Woman and Person of Color as U.S. Presidential Advisor for Science and Technology
    Health Policy

    Arati Prabhakar Becomes First Woman and Person of Color as U.S. Presidential Advisor for Science and Technology

    The U.S. Senate confirmed the appointment of Arati Prabhakar, PhD, as director of the White House Office of Science and Technology Policy and chief advisor to the president for science and technology in September 2022, making her the first woman and person of color confirmed to lead OSTP.

    November 28, 2022
    Micro-Organospheres Create Molecular Model of Patients’ Cancer in Just Two Weeks
    Cancer treatments

    Micro-Organospheres Create Molecular Model of Patients’ Cancer in Just Two Weeks

    Biomarker- and molecular-driven technologies such as molecular models can precisely predict how an individual’s cancer will respond to certain treatments, the pinnacle of precision oncology. However, established modeling systems such as patient-derived xenografts and patient-derived organoids require large tissue samples and take months or even a year to obtain results, barriers that have limited their application in regular practice.

    November 16, 2022
    What the Evidence Says About Probiotics and Cancer Immunotherapy
    Immunotherapy

    What the Evidence Says About Probiotics and Cancer Immunotherapy

    Growing evidence suggests that the gut microbiome, a diverse and complex mix of microorganisms and their metabolites, is closely linked to the immune system, and researchers are studying whether modulating the gut microbiome affects cancer immunotherapy treatment outcomes. In particular, probiotics—which are flora typically obtained through dietary sources such as yogurt and fermented foods or via supplemental forms—are gaining prominence as a potential strategy to modulate the gut microbiome during cancer treatment.

    November 15, 2022
    Cortisol Biomarkers Help Researchers Understand Chemotherapy-Induced Peripheral Neuropathy
    Chemotherapy

    Cortisol Biomarkers Help Researchers Understand Chemotherapy-Induced Peripheral Neuropathy

    Clinicians and researchers know little about the mechanisms for chemotherapy-induced peripheral neuropathy, a side effect of neurotoxic agents that can cause numbness, tingling, and pain in the upper and lower extremities. Until recently, mechanism-based treatment was difficult, but biomarkers are helping nurse scientists identify a potential connection to the hypothalamic-pituitary-adrenal axis.

    November 03, 2022
    Anthony Fauci, MD, Talks About His Legacy as He Steps Down as NIAID Director
    Research

    Anthony Fauci, MD, Talks About His Legacy as He Steps Down as NIAID Director

    Anthony Fauci, MD, reflected on his career in government and gave insight into what he’s doing next in a statement released in August 2022 addressing his departure from his positions as director of the National Institute of Allergy and Infectious Diseases (NIAID), chief of the NIAID Laboratory of Immunoregulation, and chief medical advisor to President Joe Biden. Fauci served as NIAID director for 38 years and held a career spanning more than 50 years in government service.

    November 02, 2022
    New Data Show 2.5 Million Youth Currently Use E-Cigarettes
    U.S. Food and Drug Administration (FDA)

    New Data Show 2.5 Million Youth Currently Use E-Cigarettes

    About 1 in 10 middle (3.3%) and high (14.1%) school students used e-cigarettes in the past 30 days, according to findings that the U.S. Food and Drug Administration, in coordination with the Centers for Disease Control and Prevention, reported in October 2022. In total, 2.5 million middle and high school students currently use e-cigarettes.

    October 31, 2022
    Color Out Your Stress and Anxiety
    Nurse well-being

    Color Out Your Stress and Anxiety

    More than an activity for children, many people find that the cathartic art of coloring, particularly intricate patterns and swirling mandalas, may help them destress. The first adult coloring book was published in the 1960s, but adults began embracing the idea en mass in April 2015 when illustrator Johanna Basford was featured on NPR’s All Things Considered. By the end of that year, 12 million adult coloring books were sold in the United States.

    October 27, 2022
    Researcher Reflects on How Cancer Was Reported on in the Mid-20th Century
    Research

    Researcher Reflects on How Cancer Was Reported on in the Mid-20th Century

    Our understanding of cancer has come a great ways over the past few decades, and some of the progress can be traced back to the 1950’s film Challenge: Science Against Cancer, explained David Cantor, PhD, researcher at the Instituto de Desarrollo Económico y Social, Buenos Aires Argentina, adjunct professor in the School of Public Health at the University of Maryland, College Park, in a July 2022 essay for the National Library of Medicine.

    October 19, 2022
    NIH-Funded Study on HIV Vulnerability Could Help Erase Latent HIV Infection
    Cancer risk factors

    NIH-Funded Study on HIV Vulnerability Could Help Erase Latent HIV Infection

    Patterns of sugars at the surface of immune cells can affect a person’s vulnerability to HIV infection, according to results from a study funded by the National Institutes of Health. The findings suggested it may be possible to locate infected immune cells with the last vestiges of HIV by reading sugar profiles on the surface, Lawrence Tabak, DDS, PhD, NIH acting director, said in a July 2022 blog post.

    October 18, 2022
    Diverse Nursing Research Tackles Current Medical Challenges and Looks Toward Future
    Research

    Diverse Nursing Research Tackles Current Medical Challenges and Looks Toward Future

    The National Institute of Nursing Research, an National Institutes of Health agency, released its 2022–2026 strategic plan in summer 2022 to support its mission of leading “nursing research to solve pressing health challenges and inform practice and policy—optimizing health and advancing health equity into the future.”

    October 06, 2022
    NIH Climate Change and Health Initiative Rallies Efforts to Address the Dangers of the Environment on Health
    Cancer risk factors

    NIH Climate Change and Health Initiative Rallies Efforts to Address the Dangers of the Environment on Health

    The National Institutes of Health launched the Climate Change and Health Initiative to expand knowledge and address key challenges regarding the environment’s impact on health and conditions like cancer in a collaborating all-hands-on-deck scientific effort, Richard Woychik, PhD, director of the NIH’s National Institute of Environmental Health Sciences, said in a blog post in July 2022.

    October 04, 2022
    Tea Soothes Your Soul and Supports Your Well-Being
    Nurse well-being

    Tea Soothes Your Soul and Supports Your Well-Being

    Throughout history, many generations have used a hot cup of tea to promote mental and physical wellness. The discovery of tea dates to 2732 B.C., when leaves from a wild tree blew into Chinese Emperor Shen Nung’s pot of boiling water and the pleasant scent compelled him to take a sip. The legend says that the emperor described how the liquid gave him a warm feeling that invigorated his body and soul.

    September 29, 2022
    Testicular Cancer Survivors May Need Fewer Monitoring Scans
    Cancer screening

    Testicular Cancer Survivors May Need Fewer Monitoring Scans

    Monitoring early-stage testicular cancer survivors for disease recurrence after surgery using either magnetic resonance imaging or fewer computed tomography scans is just as effective as more frequent intervals, researchers reported in study findings published in the Journal of Clinical Oncology.

    September 21, 2022
    Certain Cancers May Increase Risk of Type 2 Diabetes
    Research

    Certain Cancers May Increase Risk of Type 2 Diabetes

    Patients with lung, pancreatic, breast, brain, urinary tract, or uterine cancers may be more likely to develop new-onset type 2 diabetes after their cancer diagnosis, according to research findings published in Diabetes Care, and those who went on to develop type 2 diabetes experienced poorer overall health outcomes.

    September 14, 2022
    Nurse Scientists Are Leading Patient Care Discoveries in the Ever-Evolving World of Cancer Survivorship
    Research

    Nurse Scientists Are Leading Patient Care Discoveries in the Ever-Evolving World of Cancer Survivorship

    The cancer survivorship program team at the University of Pennsylvania Abramson Cancer Center is conducting numerous research projects such as cancer treatment’s late effects, survivors’ quality of life and health behaviors, telemedicine for survivorship visits, and even an artificial intelligence–powered, mobile phone–based program to support patient adherence to guidance from survivorship visits.

    September 13, 2022
    Drug Clinical Trials Focus on Efficacy Over Quality of Life
    Oncology clinical trials

    Drug Clinical Trials Focus on Efficacy Over Quality of Life

    The clinical trials that lead to new drug approvals or expanded indications are quick to praise a therapy’s clinical benefits, such as longer survival or time to progression, but only about one in five of those trials find improvements in patients’ quality of life, researchers reported in JAMA Oncology.

    September 07, 2022
    FDA Approves Ibrutinib for Pediatric Patients With Chronic Graft-Versus-Host Disease, Including a New Oral Suspension
    U.S. Food and Drug Administration (FDA)

    FDA Approves Ibrutinib for Pediatric Patients With Chronic Graft-Versus-Host Disease, Including a New Oral Suspension

    On August 24, 2022, the U.S. Food and Drug Administration approved ibrutinib (Imbruvica®) for pediatric patients aged less than 1 year with chronic graft-versus-host disease after failure of one or more lines of systemic therapy. Formulations include capsules, tablets, and oral suspension.

    August 25, 2022
    As Skin Cancer Screening Increases, Clinicians Find More Thin Melanomas
    Cancer screening

    As Skin Cancer Screening Increases, Clinicians Find More Thin Melanomas

    Although regular population-based skin cancer screening isn’t recommended by the U.S. Preventive Services Task Force, more Americans are getting full-body skin exams at dermatology visits or other provider services. Data from a new study published in JAMA Dermatology suggest that the screening uptick is associated with increased diagnoses of early-stage, in situ melanoma, leading the researchers to raise concerns about overdiagnosis.

    August 17, 2022
    FDA Publishes Three New Biosimilars Resources for Healthcare Providers
    U.S. Food and Drug Administration (FDA)

    FDA Publishes Three New Biosimilars Resources for Healthcare Providers

    To raise awareness and better educate patients and providers about biosimilars’ potential in clinical care, the U.S. Food and Drug Administration (FDA) added three new fact sheets to its healthcare provider resources in July 2022.

    August 11, 2022
    Single HPV Vaccine Dose May Be Enough to Prevent Cancer
    Cancer research

    Single HPV Vaccine Dose May Be Enough to Prevent Cancer

    In findings that could have global implications to change the face of female cancers, researchers reported that a single dose of the human papillomavirus (HPV) vaccine is highly effective in protecting young women against cervical infection with cancer-causing HPV types. The study results, which were published in NEJM Evidence, build on the body of evidence supporting single-dose HPV vaccines.

    August 10, 2022
    Promote Patient Self-Advocacy Across the Cancer Spectrum
    Patient advocacy

    Promote Patient Self-Advocacy Across the Cancer Spectrum

    Healthcare professionals are called to provide patient-centered care in an environment where they listen to patients’ goals and desires and support patient autonomy. However, heeding that call requires patients’ participation to voice their needs and concerns, and some patients may be reluctant to speak up for themselves.

    August 09, 2022
    Cancer Mortality Declines Among Black Patients but Remains Disproportionately High
    Cancer health disparities

    Cancer Mortality Declines Among Black Patients but Remains Disproportionately High

    Death rates fell about 2% per year from 1999–2019 for Black patients with cancer, researchers reported in study findings published in JAMA Oncology; however, the population’s cancer mortality remains higher than other racial and ethnic groups for most cancer sites.

    August 03, 2022
    What the Evidence Says About Traditional Chinese Medicine for Chronic Diarrhea
    Research

    What the Evidence Says About Traditional Chinese Medicine for Chronic Diarrhea

    Diarrhea is a distressing condition that significantly affects patients’ quality of life and social functioning. Characterized by passage of more than three unformed stools in 24 hours, in cancer it can be caused by chemotherapy, radiotherapy, laxatives and antibiotics, enteral feeding, malabsorption syndromes, colectomy, or several types of malignant tumors. Diarrhea has also been reported in long-term cancer survivors. Standard treatment options such as opiate agonists and adsorbents are associated with side effects that may increase a patient’s symptom burden.

    July 18, 2022
    Oncology Nursing QI Project Shows Normal Saline Is Comparable to Heparin for Pediatric CVCs
    Research

    Oncology Nursing QI Project Shows Normal Saline Is Comparable to Heparin for Pediatric CVCs

    Emerging evidence has consistently shown that flushing central venous catheters with normal saline is comparable to heparin flushes in the adult care setting, leading to updated guideline recommendations that include saline as an alternative. But to date, only two studies have evaluated the two options in pediatric patients, the older of which found increased complications when used in children with leukemia or lymphoma. Is normal saline an acceptable alternative in that population?

    July 12, 2022
    Genetic Disorder Reference Sheet: Multiple Endocrine Neoplasia Type 1
    Genetics & genomics

    Genetic Disorder Reference Sheet: Multiple Endocrine Neoplasia Type 1

    Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant genetic disease affecting about 1 in 30,000 people. Pathogenic variants in the MEN1 gene are associated with benign and malignant tumors in the parathyroid glands, pituitary gland, pancreas, duodenum, and stomach.

    July 07, 2022
    Healthcare Organizations Advocate for Clinical Trial Diversity in Letter to Congress
    Clinical practice

    Healthcare Organizations Advocate for Clinical Trial Diversity in Letter to Congress

    Healthcare organizations advocated to improve diversity among clinical trials in a letter sent to U.S. Congress in May encouraging the government to take steps as the reauthorization of the Prescription Drug User Fee Act (PDUFA) approaches. The PDUFA allows the U.S. Food and Drug Administration to review and approve drugs, but the authorization is set to expire in September of 2022.

    June 28, 2022
    FDA Says It’s Continuing to Evaluate Pulse Oximeters’ Race-Related Accuracy and Limitations
    U.S. Food and Drug Administration (FDA)

    FDA Says It’s Continuing to Evaluate Pulse Oximeters’ Race-Related Accuracy and Limitations

    More than a year and a half after a report suggesting a potential racial bias in pulse oximeter technology first surfaced as a letter to the editor in the New England Journal of Medicine (NEJM), on June 21, 2022, the U.S. Food and Drug Administration (FDA) said that it is continuing its investigation into the devices’ accuracy and performance, particularly among people of color.

    June 27, 2022
    Maintain Oral Adherence With ONS Guidelines™
    Research

    Maintain Oral Adherence With ONS Guidelines™

    With so many of today’s cancer treatments administered orally, ensuring that patients adhere to their regimen as prescribed is essential to optimal outcomes. According to the World Health Organization, medication adherence is the single most important modifiable factor that affects treatment outcomes.

    June 14, 2022
    Naive T-Cell Depletion Prevents Chronic GVHD in Transplantation Survivors
    Cancer research

    Naive T-Cell Depletion Prevents Chronic GVHD in Transplantation Survivors

    A novel stem cell transplantation strategy reduces both the incidence and severity of chronic graft-versus-host disease (GVHD) in patients with acute leukemia, researchers reported in the Journal of Clinical Oncology. The investigational treatment removes naïve T cells from donor cells before transplanting into patients.

    June 01, 2022
    Decree Houses ARPA-H Under NIH Oversight
    Health Policy

    Decree Houses ARPA-H Under NIH Oversight

    Since President Joe Biden announced the creation of the Advanced Research Projects Agency for Health (ARPA-H) in October 2021, the National Cancer Institute and National Institutes of Health (NIH) shared responsibility for implementing its goals to improve the U.S. government’s ability to speed biomedical and health research. In April 2022, the U.S. Department of Health and Human Services (HHS) officially placed the agency under NIH.

    May 31, 2022
    Spring Clean Your Home and Heart
    Nurse well-being

    Spring Clean Your Home and Heart

    Slowing down to recenter can often feel unrealistic amid a nurse’s competing priorities. However, cultivating internal and external stability can improve life at the bedside and beyond. A clean home and heart can make it easier for us to navigate day-to-day responsibilities and engage in the love and relaxation we deserve as the day winds down.

    May 26, 2022
    Use the Evidence to Integrate Ethics  in Teleoncology Care
    Oncology nurse-patient relationship

    Use the Evidence to Integrate Ethics in Teleoncology Care

    Emily manages a rural clinic associated with an academic cancer center. Patients initially have an in-person consultation with their treating oncologists at the main campus but then use telehealth for subsequent visits. To support patients during teleoncology visits, Emily wants to initiate a plan to collaborate with the clinic staff to identify and address the ethical principles for oncology care using telehealth.

    May 17, 2022
    AI Ultrasound Is Nearly 100% Accurate in Detecting Thyroid Cancers
    Cancer research

    AI Ultrasound Is Nearly 100% Accurate in Detecting Thyroid Cancers

    Ultrasound imaging guided with artificial intelligence (AI) noninvasively detects almost all malignant thyroid nodules, researchers reported at the 2022 Multidisciplinary Head and Neck Cancers Symposium. It is also accurate when predicting T stage, extracapsular extension, and presence of a BRAF variant.

    May 11, 2022
    Oncology Navigation Standards Help Patients Overcome Disparities and Barriers to Care
    Cancer health disparities

    Oncology Navigation Standards Help Patients Overcome Disparities and Barriers to Care

    Patients with cancer, especially those from underrepresented groups or who are experiencing racism, inequalities, social determinants of health factors, and other barriers to care, need oncology nurse navigation now more than ever before. Developed as a “strategy to improve outcomes in marginalized populations by eliminating barriers to timely diagnosis and treatment of cancer and other chronic diseases,” navigation has made a difference for patients since its introduction in 1990.

    May 10, 2022
    U.S. Representative Pallone Questions Vaping Companies on Teen Marketing
    Cancer risk prevention

    U.S. Representative Pallone Questions Vaping Companies on Teen Marketing

    As the U.S. Food and Drug Administration (FDA) continues its review of tobacco and e-cigarette products’ marketing applications, legislators and government officials, such as Energy and Commerce Committee Chair Frank Pallone, Jr. (D-NJ), are taking a stand and sharing their concerns on Big Tobacco’s marketing to teenage audiences.

    May 05, 2022
    More Patients Are Skipping Their Cervical Cancer Screenings
    Research

    More Patients Are Skipping Their Cervical Cancer Screenings

    Nearly a quarter of patients who are eligible for cervical cancer screening are overdue for their current tests, researchers said in study findings published in JAMA Network Open. The number grew nearly 10% since 2005—representing a steady increase in missed screening over time—and was higher in different sociodemographic groups because of factors related to social determinants of health.

    May 04, 2022
    CAR T-Cell Therapy Programs
    Cancer treatments

    CAR T-Cell Therapy Programs

    Debuting in human clinical trials just a decade ago, chimeric antigen receptor (CAR) T-cell therapy was quickly hailed as a breakthrough cancer treatment for certain hematologic cancers. Today, patients and providers have access to 22 U.S. Food and Drug Administration (FDA)–approved cellular and gene therapy products, and CAR T-cell therapy is available beyond large academic research centers.

    May 03, 2022
    Robert Otto Valdez Appointed AHRQ Director
    Research

    Robert Otto Valdez Appointed AHRQ Director

    Internationally recognized for expertise in health services research, the U.S. healthcare system, and health policy analysis, Robert Otto Valdez, PhD, MHSA, was appointed as director of the Agency for Healthcare Research and Quality (AHRQ) in February 2022, where he leads the agency’s work in improving and promoting patient safety.

    April 20, 2022
    Younger Nurses Are Leaving the Profession Because of Emotional Health
    Nurse well-being

    Younger Nurses Are Leaving the Profession Because of Emotional Health

    Young nurses are “less emotionally healthy and less optimistic about the future,” even after accounting for age and years of nursing experience, according to findings from a 2022 study conducted by the American Nurses Foundation. High levels of burnout correlate with drones of professionals leaving the nursing field, the foundation said in its Pulse on the Nation’s Nurses Survey Series: COVID-19 Two-Year Impact Assessment Survey.

    April 07, 2022
    What the Evidence Says About Low-Intensity Exercise in Cancer Care
    Complementary therapy

    What the Evidence Says About Low-Intensity Exercise in Cancer Care

    Regular, light-intensity exercise and activity has been shown to reduce the risks of fractures, heart disease, and death. Substantial evidence also indicated benefits for cancer-related outcomes, including fatigue, depression, and quality of life. Additional observational data suggested that sustained physical activity may help reduce cancer recurrence and improve overall survival.

    March 30, 2022
    Nursing Diversity Is Critical to Address Health Disparities
    Oncology nurse influence

    Nursing Diversity Is Critical to Address Health Disparities

    Following the death of George Floyd in May 2020, I found myself surrounded by oncology nurses who recognized the need for immediate action to understand and deconstruct racism, and I began collecting resources to offer continuing education about the effects of racism on cancer outcomes and actions nurses can take to support health equity and diversity in the workforce. Under the mentorship of ONS Past President Mary Gullatte, PhD, RN, ANP-BC, AOCN®, FAAN, I was charged by ONS to co-lead, with ONS member Randy Jones, PhD, RN, FAAN, a national team of ONS cancer disparities and health equity researchers to update the ONS Research Agenda.

    March 08, 2022
    E-Cigarettes Affect Adults and Kids Differently, FDA Center for Tobacco Products Director Says
    Patient safety

    E-Cigarettes Affect Adults and Kids Differently, FDA Center for Tobacco Products Director Says

    Balancing the benefits of e-cigarettes for adults with the harms makes regulating e-cigarette marketing particularly challenging, U.S. Food and Drug Administration (FDA) Center for Tobacco Products Director Mitch Zeller, JD, said in a January 2022 interview with the National Cancer Institute (NCI). FDA continuously evaluates e-cigarettes and tobacco companies’ marketing strategies, and Zeller says it’s up to tobacco companies to make those differences clear in their advertising.

    February 23, 2022
    New HHS Initiative Will Reduce Maternal and Infant Health Disparities
    Cancer health disparities

    New HHS Initiative Will Reduce Maternal and Infant Health Disparities

    To reduce the disparities affecting maternity health outcomes, the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) launched the Maternal Morbidity and Mortality Data and Analysis Initiative, an $8 million contract with Premier, Inc., the agency announced in December 2021. The initiative is rallying a network of hospitals to deploy evidence-based best practices in maternity care.

    January 14, 2022
    Families See Increase in Healthcare Premiums, Increase in Covered Services
    Patient resources

    Families See Increase in Healthcare Premiums, Increase in Covered Services

    Employer-sponsored health insurance premiums increased by 4% for families in 2021, bringing the average annual cost to $22,221 per family, according to the results of a benchmark Kaiser Family Foundation (KFF) Employer Health Benefits survey released in November 2021. KFF also assessed the COVID-19 pandemic’s impact on workplace health benefits, including telemedicine and mental health services.

    January 13, 2022
    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9
    • Next page
    • Last page Last »
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    • Immunotherapy
    View All Topics
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲